J Neurol Surg A Cent Eur Neurosurg 2021; 82(03): 225-231
DOI: 10.1055/s-0040-1719080
Original Article

Outcome Features Analysis in Intramedullary Tumors of the Cervicomedullary Junction: A Surgical Series

1   Department of Oncology and Hemato-Oncology, University of Milan, Milano, Lombardia, Italy
2   Division of Neurosurgery, La Fondazione IRCCS Ca' Granda Ospedale Maggiore di Milano Policlinico, Milano, Lombardia, Italy
,
Giacoma Maria Floriana Brunetto*
3   Department of Human Neurosciences, University of Rome La Sapienza, Roma, Lazio, Italy
,
Alessandro Landi
4   Department of Neurosurgery, Sapienza University of Rome, Rome, Italy
,
4   Department of Neurosurgery, Sapienza University of Rome, Rome, Italy
,
Francesca Santoro
5   Department of Neuroradiology, Regional Hospital San Carlo, Potenza, Basilicata, Italy
,
Alessandro Frati
6   Division of Neurosurgery, IRCCS Istituto Neurologico Mediterraneo NEUROMED, Pozzilli, Molise, Italy
,
Roberto Delfini
7   Department of Neurology and Psychiatry, “Sapienza,” University of Rome, Rome, Italy
,
Antonio Santoro
8   Department of Neurology and Psychiatry, Endovascular Neurosurgery/Interventional Neuroradiology, “Sapienza” University of Rome, Rome, Italy
› Author Affiliations

Abstract

Object The aim of this study is to investigate the impact of surgery for different cervicomedullary lesions on symptomatic pattern expression and postoperative outcome. We focused on specific outcome features of the early and late postoperative assessments. The former relies on surgery-related transient and permanent morbidity and feasibility of radicality in eloquent areas, whereas the latter on long-term course in lower grade tumors and benign tumorlike lesions (cavernomas, etc.).

Material and Methods We retrospectively analyzed 28 cases of intramedullary tumors of the cervicomedullary junction surgically treated at our institution between 1990 and 2018. All cases were stratified for gender, histology, macroscopic appearance, location, surgical approach, and presence of a plane of dissection (POD). Mean follow-up was 5.6 years and it was performed via periodic magnetic resonance imaging (MRI) and functional assessments (Karnofsky Performance Scale [KPS] and modified McCormick [MC] grading system).

Results In all, 78.5% were low-grade tumors (or benign lesions) and 21.5% were high-grade tumors. Sixty-one percent underwent median suboccipital approach, 18% a posterolateral approach, and 21% a posterior cervical approach. Gross total resection was achieved in 54% of cases, near-total resection (>90%) in 14%, and subtotal resection (50–90%) in 32% of cases. Early postoperative morbidity was 25%, but late functional evaluation in 79% of the patients showed KPS > 70 and MC grade I; only 21% of cases showed KPS < 70 and MC grades II and III at late follow-up. Mean overall survival was 7 years in low-grade tumors or cavernomas and 11.7 months in high-grade tumors. Progression-free survival at the end of follow-up was 71% (evaluated mainly on low-grade tumors).

Conclusions The surgical goal should be to achieve maximal cytoreduction and minimal postoperative neurologic damage. Functional outcome is influenced by the presence of a POD, radicality, histology, preoperative status, and employment of advanced neuroimaging planning and intraoperative monitoring.

* Authors equally contributed to the manuscript.




Publication History

Received: 07 October 2019

Accepted: 28 August 2020

Article published online:
04 February 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Samartzis D, Gillis CC, Shih P, O'Toole JE, Fessler RG. Intramedullary spinal cord tumors: part I-epidemiology, pathophysiology, and diagnosis. Global Spine J 2015; 5 (05) 425-435
  • 2 Nair AP, Mehrotra A, Das KK, Srivastava AK, Sahu RN, Kumar R. Clinico-radiological profile and nuances in the management of cervicomedullary junction intramedullary tumors. Asian J Neurosurg 2014; 9 (01) 21-28
  • 3 Cooper JD, Salehi A, Delcroix JD. et al. Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Proc Natl Acad Sci U S A 2001; 98 (18) 10439-10444
  • 4 Epstein F, McCleary EL. Intrinsic brain-stem tumors of childhood: surgical indications. J Neurosurg 1986; 64 (01) 11-15
  • 5 Apuzzo MLJ. Patterns of tumor growth and problems associated with histological typing of low-grade gliomas. In: Benign Cerebral Glioma. Vol. 1. Park Ridge, IL: American Association of Neurological Surgeons Publications; 1995: 125-147
  • 6 Squires LA, Constantini S, Miller DC, Epstein F. Diffuse infiltrating astrocytoma of the cervicomedullary region: clinicopathologic entity. Pediatr Neurosurg 1997; 27 (03) 153-159
  • 7 McAbee JH, Modica J, Thompson CJ. et al. Cervicomedullary tumors in children. J Neurosurg Pediatr 2015; 16 (04) 357-366
  • 8 Setzer M, Murtagh RD, Murtagh FR. et al. Diffusion tensor imaging tractography in patients with intramedullary tumors: comparison with intraoperative findings and value for prediction of tumor resectability. J Neurosurg Spine 2010; 13 (03) 371-380
  • 9 Landi A, Palmarini V, D'Elia A. et al. Magnetic resonance diffusion tensor imaging and fiber-tracking diffusion tensor tractography in the management of spinal astrocytomas. World J Clin Cases 2016; 4 (01) 1-4
  • 10 Cohen AR. Surgical Disorders of the Fourth Ventricle. Oxford: Blackwell Science; 1996
  • 11 Kempe LG. Operative Neurosurgery. Berlin: Springer-Verlag; 1970
  • 12 Kempe LG. Operative Neurosurgery. Vol. 2. Posterior Fossa, Spinal Cord, and Peripheral Nerve Disease. Berlin: Springer-Verlag; . Accessed December 14, 2018. https://link.springer.com/content/pdf/bfm%3A978-3-662-12631-8%2F1.pdf
  • 13 Tanriover N, Ulm AJ, Rhoton Jr AL, Yasuda A. Comparison of the transvermian and telovelar approaches to the fourth ventricle. J Neurosurg 2004; 101 (03) 484-498
  • 14 Karam YR, Menezes AH, Traynelis VC. Posterolateral approaches to the craniovertebral junction. Neurosurgery 2010; 66 (03) 135-140
  • 15 Wen HT, Rhoton Jr AL, Katsuta T, de Oliveira E. Microsurgical anatomy of the transcondylar, supracondylar, and paracondylar extensions of the far-lateral approach. J Neurosurg 1997; 87 (04) 555-585
  • 16 Sala F, Bricolo A, Faccioli F, Lanteri P, Gerosa M. Surgery for intramedullary spinal cord tumors: the role of intraoperative (neurophysiological) monitoring. Eur Spine J 2007; 16 (Suppl. 02) S130-S139
  • 17 Kothbauer KF. Intraoperative neurophysiologic monitoring for intramedullary spinal-cord tumor surgery. Neurophysiol Clin 2007; 37 (06) 407-414
  • 18 Constantini S, Miller DC, Allen JC, Rorke LB, Freed D, Epstein FJ. Radical excision of intramedullary spinal cord tumors: surgical morbidity and long-term follow-up evaluation in 164 children and young adults. J Neurosurg 2000; 93 (02) 183-193
  • 19 Brotchi J, Dewitte O, Levivier M. et al. A survey of 65 tumors within the spinal cord: surgical results and the importance of preoperative magnetic resonance imaging. Neurosurgery 1991; 29 (05) 651-656 , discussion 656–657
  • 20 Sandalcioglu IE, Gasser T, Asgari S. et al. Functional outcome after surgical treatment of intramedullary spinal cord tumors: experience with 78 patients. Spinal Cord 2005; 43 (01) 34-41
  • 21 Hanbali F, Fourney DR, Marmor E. et al. Spinal cord ependymoma: radical surgical resection and outcome. Neurosurgery 2002; 51 (05) 1162-1172 , discussion 1172–1174
  • 22 Hoshimaru M, Koyama T, Hashimoto N, Kikuchi H. Results of microsurgical treatment for intramedullary spinal cord ependymomas: analysis of 36 cases. Neurosurgery 1999; 44 (02) 264-269
  • 23 Garcés-Ambrossi GL, McGirt MJ, Mehta VA. et al. Factors associated with progression-free survival and long-term neurological outcome after resection of intramedullary spinal cord tumors: analysis of 101 consecutive cases. J Neurosurg Spine 2009; 11 (05) 591-599
  • 24 McGirt MJ, Goldstein IM, Chaichana KL, Tobias ME, Kothbauer KF, Jallo GI. Extent of surgical resection of malignant astrocytomas of the spinal cord: outcome analysis of 35 patients. Neurosurgery 2008; 63 (01) 55-60 , discussion 60–61
  • 25 Innocenzi G, Raco A, Cantore G, Raimondi AJ. Intramedullary astrocytomas and ependymomas in the pediatric age group: a retrospective study. Childs Nerv Syst 1996; 12 (12) 776-780
  • 26 Ferrante L, Mastronardi L, Celli P, Lunardi P, Acqui M, Fortuna A. Intramedullary spinal cord ependymomas: a study of 45 cases with long-term follow-up. Acta Neurochir (Wien) 1992; 119 (1–4): 74-79
  • 27 Jallo GI, Danish S, Velasquez L, Epstein F. Intramedullary low-grade astrocytomas: long-term outcome following radical surgery. J Neurooncol 2001; 53 (01) 61-66
  • 28 Samii M, Klekamp J. Surgical results of 100 intramedullary tumors in relation to accompanying syringomyelia. Neurosurgery 1994; 35 (05) 865-873 , discussion 873
  • 29 Cristante L, Herrmann HD. Surgical management of intramedullary spinal cord tumors: functional outcome and sources of morbidity. Neurosurgery 1994; 35 (01) 69-74 , discussion 74–76
  • 30 Sofuoğlu ÖE, Abdallah A. Pediatric spinal ependymomas. Med Sci Monit 2018; 24: 7072-7089
  • 31 Karikari IO, Nimjee SM, Hodges TR. et al. Impact of tumor histology on resectability and neurological outcome in primary intramedullary spinal cord tumors: a single-center experience with 102 patients. Neurosurgery 2015; 76 (Suppl. 01) S4-S13 , discussion S13
  • 32 Kutluk T, Varan A, Kafalı C. et al. Pediatric intramedullary spinal cord tumors: a single center experience. Eur J Paediatr Neurol 2015; 19 (01) 41-47